Merck unit held liable in Australian Vioxx case

LONDON (Reuters) - Drugmaker Merck & Co's one-time blockbuster arthritis drug Vioxx doubled the risk of heart attacks and was not fit for sale, an Australian court said on Friday, in a ruling against the U.S. group's Australian unit.

Continue to Merck unit held liable in Australian Vioxx case on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz